Biocross
e4Risk Quantitative
Biomarkers / Diagnostic
Central Nervous System
Determination of ApoE4 plasma quantification as a reliable predictor of pathological concentrations of Abeta peptide, Tau and phosphotau in cerebrospinal fluid of patients with clinical suspiction of Alzheimer�s Disease.
2Preclinical Validation,
1R+D